SCHEMBL19165883

SCHEMBL19165883

c1ccc(-c2nc(-c3cccc(-c4ccncc4)c3)nc(-c3cc(-c4ccc5oc6ccccc6c5c4)cc(-c4ccc5oc6ccccc6c5c4)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.43
▸ PLA2G4A P47712 3/20 0.43
▸ PLA2G10 O15496 1/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ MAPT P10636 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ DYRK1A Q13627 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.41
▸ PIK3CA P42336 1/20 0.40
▸ MAPK14 Q16539 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ NOTUM Q6P988 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19165225 0.99 SMN1; SMN2 (0.43) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL22136861 0.97 SMN1; SMN2 (0.44) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL22136891 0.97 SMN1; SMN2 (0.44) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL22136602 0.95 SMN1; SMN2 (0.41) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL22136857 0.95 SMN1; SMN2 (0.42) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL15501504 0.93 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL15501672 0.93 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL15501471 0.93 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL25646021 0.93 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT
SCHEMBL15501440 0.93 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-09-22 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback